This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Rafael A Medina-Silva: Innovator in Influenza Virus Vaccines
Introduction
Rafael A Medina-Silva is a prominent inventor based in Santiago, Chile. He has made significant contributions to the field of virology, particularly in the development of influenza virus vaccines. His innovative work has the potential to impact public health positively.
Latest Patents
Medina-Silva holds a patent for "Influenza virus vaccines and uses thereof." This patent includes flu hemagglutinin polypeptides, including chimeric influenza virus hemagglutinin polypeptides. It also covers flu hemagglutinin polypeptides comprising modified glycosylation sites and non-naturally glycosylation sites, along with compositions and vaccines that utilize these innovations. He has 1 patent to his name.
Career Highlights
Medina-Silva is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts research and develops new vaccine technologies. His work is crucial in the ongoing fight against influenza and other viral diseases.
Collaborations
He has collaborated with notable scientists in the field, including Adolfo Garcia-Sastre and Peter M Palese. These partnerships enhance the research and development of effective vaccines.
Conclusion
Rafael A Medina-Silva is a key figure in the advancement of influenza virus vaccines. His innovative contributions and collaborations are paving the way for improved public health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile